Results 151 to 160 of about 12,722 (192)

A propensity score-matched retrospective study on sacubitril/valsartan use and 6-month readmission rates in patients with acute heart failure. [PDF]

PeerJ
Zhang L, Chen Q, Ren G.
europepmc   +1 more source

The Effectiveness of Sacubitril/Valsartan in Systemic Sclerosis Patients with Heart Failure: A Retrospective Analysis. [PDF]

J Clin Med
Eshak N, Abdelnabi M, Quillen J, Pham M, Hentz J, Nagaraja V.   +5 more
europepmc   +1 more source

Predicting cardiac and renal responses to sacubitril/valsartan with a mathematical model of heart failure with preserved ejection fraction. [PDF]

Am J Physiol Heart Circ Physiol
Clemmer JS, Hall ME, Mallette JH, Pruett WA.   +3 more
europepmc   +1 more source

A real-world pharmacovigilance analysis of acute renal failure associated with sacubitril/valsartan based on FDA Adverse Event Reporting System (FAERS). [PDF]

PLoS One
Wang S, Lai J, Chen J, Luo Q, Yi W, Lai Y.   +5 more
europepmc   +1 more source

The addition of vericiguat to sacubitril/valsartan improved the composite endpoint. Add a finishing touch on heart failure medical therapy by vericiguat as secret ingredient. [PDF]

Eur J Heart Fail
Kinoshita H, Sugino H, Kodama M, Saito M, Sumimoto Y, Masada K, Shimonaga T, Suga A, Toko M, Taniyasu K, Ushirozako S, Katayama Y, Hirahara C, Takada M.   +13 more
europepmc   +1 more source

Successful Management of HFpEF-Related Pulmonary Hypertension With Systemic-Level Pressures Using Sacubitril-Valsartan and Empagliflozin. [PDF]

JACC Case Rep
Abofrekha B, Shadi M, Jdaidani J, Rojas-Marte GR.   +3 more
europepmc   +1 more source

Dual therapy with vildagliptin and sacubitril/valsartan alleviates portal hypertension and inhibits soluble epoxide hydrolase in cirrhotic rats. [PDF]

World J Gastroenterol
Oyama M, Kaji K, Nishimura N, Hanatani J, Nakatani T, Nishimura N, Shibamoto A, Asada S, Tsuji Y, Kitagawa K, Sato S, Namisaki T, Yoshiji H.   +12 more
europepmc   +1 more source

The Effect of Sacubitril/Valsartan on Supraventricular and Ventricular Arrhythmias in Patients With Heart Failure. [PDF]

Ann Noninvasive Electrocardiol
Arzhangzadeh A, Nikoo MH, Haghjoo M, Rasekh F, Shojaei S, Mousavi A, Nozhat S, Narimani-Javid R, Bazroodi H, Neisi S, Mojibpour M, Abedini M, Eslamzadeh S, Drissi HB, Shafiei S.   +14 more
europepmc   +1 more source

Sacubitril/Valsartan and Prevention of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy: The PRADA II Randomized Clinical Trial. [PDF]

Circulation
Omland T, Heck SL, Holte E, Lilleaasen AM, Gynnild MN, Fagerland MW, Vinje-Jakobsen V, Næs AL, Blix ES, Larsen AI, Geisler J, Gulati G, Wethal T.   +12 more
europepmc   +1 more source

Effects of Sacubitril/Valsartan on Blood Pressure and Proteinuria in Hypertensive Patients With Chronic Kidney Disease. [PDF]

J Clin Hypertens (Greenwich)
Murakoshi M, Kobayashi T, Kihara M, Ueda S, Suzuki Y, Gohda T.   +5 more
europepmc   +1 more source